Prophylaxis for Recurrent UTI in Healthy Adult Women

Introduction to Prophylaxis

The European Association of Urology recommends starting with behavioral modifications and vaginal estrogen if postmenopausal, then using continuous daily antibiotic prophylaxis with nitrofurantoin 50-100 mg at bedtime for 6-12 months if non-antimicrobial measures fail, for a healthy adult woman with recurrent UTIs 1, 2

Before initiating any prophylactic regimen, confirmation of eradication of the current infection with a negative urine culture obtained 1-2 weeks after completing treatment is necessary, as starting prophylaxis on top of an active infection leads to treatment failure and resistance development, according to the European Urology guidelines 1, 3
A urine culture with antimicrobial susceptibility testing should be obtained to guide antibiotic selection based on the patient's specific pathogen patterns and resistance profile, as recommended by the European Urology guidelines 1, 3

For postmenopausal women, the European Urology guidelines recommend starting with vaginal estrogen (cream or ring) as first-line therapy before considering antibiotics, which reduces recurrence by 75% 1, 4
For premenopausal women, the European Urology guidelines suggest beginning with behavioral modifications, including increased fluid intake, voiding after intercourse, and avoiding spermicides, before proceeding to antibiotic prophylaxis if these measures fail 1, 3

The European Urology guidelines recommend nitrofurantoin 50-100 mg once daily at bedtime as the preferred first-line prophylactic agent due to low resistance rates and minimal disruption of protective vaginal flora, to be continued for 6-12 months 1, 3
Trimethoprim-sulfamethoxazole 40/200 mg (half of a single-strength tablet) once daily is highly effective but requires checking local resistance patterns first, according to the European Urology guidelines 1, 3

The European Urology guidelines strongly recommend immunoactive prophylaxis with OM-89 (Uro-Vaxom) to reduce recurrent UTI in all age groups, which can be used as monotherapy or combined with other measures 1, 4
Methenamine hippurate 1 gram twice daily has strong evidence (relative risk 0.24) for women without urinary tract abnormalities and should be considered before antibiotics, according to the European Urology guidelines 4

The European Urology guidelines advise against treating asymptomatic bacteriuria, as it increases antimicrobial resistance and paradoxically increases symptomatic infection rates, and only treating documented symptomatic infections confirmed by urine culture 1, 4
Broad-spectrum antibiotics or fluoroquinolones should not be used for prophylaxis, as they disrupt protective vaginal and periurethral microbiota, leading to more recurrences and driving resistance, according to the European Urology guidelines 1, 3